Mobile patient bed

Mobile patient bed
Colin Kerr
Colin Kerr
Published: Wednesday, November 1, 2017
Johnson & Johnson Vision’s CATALYS System Mobile Patient Bed has received FDA clearance for sale in the United States and will be available for sale this month. “Our goal with this innovation is to enhance patients’ overall surgical experience, so we worked to provide an easy transition as they move from one part of their cataract procedure to the next and premium comfort while they are in the operating room,” said Tom Frinzi, Worldwide President, Surgical Vision, at Johnson & Johnson Vision. “We also designed the mobility and adaptability features of this bed to help simplify the workflow for surgeons between the laser cataract suite and phacoemulsification.” www.jnjvision.com
Tags: patient care
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...